Abstract
Studies have shown abnormal pituitary hormone responses to neuroendocrine agonists in autistic subjects. Two probes (clonidine and L-Dopa) were used to investigate neuroendocrine responses through changes in growth hormone levels. Seven medication-free autistic subjects (ages 6.6 to 19.1) were evaluated and compared to 14 normal controls. Growth hormone was collected at 30-min intervals during the entire study. Clonidine was administered first (dose: 0.15 mgm 2 ), and samples were collected for 180 min. L-Dopa was then administered (dose: 250 mg for subjects <70 lb and 500 mg for subjects >70 lb), and samples were collected for 120 min. There was no difference in the amplitude of the clonidine or L-Dopa peak growth hormone responses in the control versus the autistic subjects. In the autistic subjects, the L-Dopa-stimulated growth hormone peak was delayed and the clonidine growth hormone peak was premature. A statistical difference with the control subjects was found when consideration was given to both the premature response of growth hormone to clonidine and the delayed response to L-Dopa (p=.01, Fisher's Exact Test). These findings suggest possible abnormalities of both dopaminergic and noradrenergic neurotransmission in subjects with autism.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agahajonion, G. K., Haigler, H. J., & Bennett, J. L. (1975). Amine receptors in CNS: III. In L. L. Iverson, S. D. Iverson, & S. H. Snyder (Eds.),Handbook of psychopharmacology (Vol. 6, pp. 63–96). New York: Plenum Press.
Campbell, M., Anderson, L., Meier, M., Cohen, I., Small, A., Samit, C., & Sacher, E. (1978). A comparison of haloperidol, behavior therapy and their interaction in autistic children.Journal of the American Academy of Child Psychiatry, 17, 640–655.
Campbell, M., Hollander, C. S., Ferris, S., & Greane, L. W. (1978). Response to thyrotropin releasing hormone stimulation in young psychotic children: A pilot study.Psychoneuroendocrinology, 3, 195–201.
Cohen, D. J., Caparulo, B. K., Shaywitz, B. A., & Bowers, M. B. (1977). Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid.Archives of General Psychiatry, 34, 545–550.
Cohen, D. J., & Young, J. G. (1977). Neurochemistry in child psychiatry.Journal of the American Academy of Child Psychiatry, 16, 353–411.
Cooper, J., Bloom, F., & Roth, R. (1982). Catecholamines II: CNS aspects. In J. Cooper, F. Bloom, & R. Roth (Eds.),The biochemical basis of neuropharmacology (4th ed.). New York: Oxford University Press.
Corn, T. H., Thompson, C., & Checkley, S. A. (1984). Effects of desipramine treatment upon central adrenoceptor function in normal subjects.British Journal of Psychiatry, 145, 139–145.
Deutsch, S., Campbell, M., Sachar, E., Green, W., & David, R. (1985). Plasma growth hormone response to oral L-Dopa in infantile autism.Journal of Autism and Developmental Disorders, 15, 205–212.
Deutsch, S., Campbell, M., Perry, R., Green, W., Poland, R., & Ruben, R. (1986). Plasma growth hormone response to insulin-induced hypoglycemia in infantile autism: A pilot study.Journal of Autism and Developmental Disorders, 16, 59–68.
Garnier, C., Comoy, E., Barthelemy, C., Leddef, I., Garreau, B., Muh, J., & Lelord, G. (1986). Dopamine beta-hydroyxlase and homovanillic acid in autistic children.Journal of Autism and Developmental Disorders, 16, 23–30.
Gillberg, C., Svennerholm, L., & Hamilton-Hellberg, C. (1983). Childhood psychosis and monoamine metabolites in spinal fluid.Journal of Autism and Developmental Disorders, 13, 383–396.
Hashino, Y., Ohno, Y., Murata, S., Yokoyama, F., Kaneko, M., & Kumashiro, H. (1984). Dexamethasone suppression test in autistic children.Folia Psychiatrica et Neurologica Japonica, 38, 445–449.
Jensen, J., Realmuto, G., & Garfinkel, B. (1985). The Dexamethasone Suppression Test in infantile autism.Journal of the American Academy of Child Psychiatry, 24, 263–265.
Lake, C. R., Ziegler, M., & Murphy, D. L. (1977). Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.Archives of General Psychiatry, 34, 553–556.
Landgrebe, A., & Landgrebe, M. (1976). Urinary catecholamine studies in autistic children. In M. Coleman (Ed.),The autistic syndromes. Amsterdam: North Holland.
Maher, K. R., Harper, J. F., MacLeay, A., & King, M. G. (1975). Peculiarities in the endocrine response to insulin stress in early infantile autism.Journal of Nervous and Mental Disease, 161, 180–184.
McBride, A., Anderson, G., Hertzig, M., Sweeney, J., Kream, J., Cohen, D., & Mann, J. (1989). Serotonergic responsivity in male young adults with autistic disorder.Archives of General Psychiatry, 46, 213–221.
Minderaa, R., Anderson, G., Volkmar, F., Akkerhuis, G., & Cohen, D. (1989). Neurochemical study of dopamine functioning in autistic and normal subjects.Journal of the American Academy of Child and Adolescent Psychiatry, 28, 190–194.
Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E., Saeger, K., & Plotkin, S. (1970). Increased blood serotonin and platelets in early infantile autism.Archives of General Psychiatry, 23, 566–572.
Schain, R., & Freedman, D. (1961). Studies of 5-hydroxyendole metabolism in autistic and other mentally retarded children.Journal of Pediatrics, 58, 315–320.
Weldon, V. V., Gupta, S., Haymond, M., Pagleara, A., Jacobs, L., & Daughaday, W. (1973). The use of L-Dopa in the diagnosis of hyposomatotropism in children.Journal of Clinical Endocrinology and Metabolism, 36, 42–46.
Winsberg, B., Sverd, J., Castells, S., Hurwic, M., & Perel, J. (1980). Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations in spinal fluid and autistic children.Neuropaediatrics, 11, 250–255.
Yamazaki, K., Saito, Y., Ikada, F., Fujieda, T., & Yamashita, I. (1975). An application of neuroendocrinological studies in autistic children and Heller's syndrome.Journal of Autism and Childhood Schizophrenia, 5, 323–332.
Yuwiler, A., Ritvo, E., Geller, E., Glousman, R., Schneiderman, G., & Matsuno, D. (1975). Uptake and afflux of serotonin from platelets of autistic and nonautistic children.Journal of Autism and Childhood Schizophrenia, 5, 83–98.
Young, J., Cohen, D., Brown, S., & Caparulo, B. (1978). Decreased urinary free catecholamine in childhood autism.Journal of the American Academy of Child Psychiatry, 17, 671–678.
Young, J., Cohen, D., Caparulo, B., Brown, S., & Maas, J. (1979). Decreased 24-hour urinary MHPG in childhood autism.American Journal of Psychiatry, 136, 1055–1057.
Author information
Authors and Affiliations
Additional information
The authors thank Dorothee Aeppli for statistical consultation, Mary Bennett for clerical assistance, Lois Laitinen for secretarial support, and the Twin Cities Society for Autistic Children for access to patient recruitment. This study was supported in part by a grant from the Alex Kunin Foundation.
Rights and permissions
About this article
Cite this article
Realmuto, G.M., Jensen, J.B., Reeve, E. et al. Growth hormone response to L-Dopa and clonidine in autistic children. J Autism Dev Disord 20, 455–465 (1990). https://doi.org/10.1007/BF02216052
Issue Date:
DOI: https://doi.org/10.1007/BF02216052